Results 141 to 150 of about 3,816 (188)

Knowledge, practices, and recognition ability of counterfeit medicines among lebanese community pharmacists during concurrent national crises. [PDF]

Sci Rep
Mourad N, Haddad C, Sacre H, Tawil SA, Zeenny RM, Younes S, Rahal M, Mourad L, Baalbaki R, Hamdan M, Kanaan S, Salameh P.   +11 more
europepmc   +1 more source

Post-market quality monitoring of medicines in Christian Health Association of Ghana health institutions. [PDF]

Ghana Med J
Arhinful DK, Yeboah P, Duah J, Antwi MA, Attachey A, Karikari-Boateng E, Awal AM, Rinke de Wit TF, Kretchy IA.   +8 more
europepmc   +1 more source

Drug recall, its frequencies and conclusion: a retrospective secondary analysis involving 2-year publicly available data from Nepal. [PDF]

Ther Adv Drug Saf
Barma S, Pathak N, Dhungana S, Jha PK, Shrestha S.   +4 more
europepmc   +1 more source

Moving beyond a legacy paradigm: A vision for equitable access to quality medicines in Africa. [PDF]

Int J Gynaecol Obstet
Doi N, Orji BC, Ruffo M, Mukumbayi P, Kibonge S, Muthamia MM, Tappis H, Biayi F, Kassim TY, Ndwiga A.   +9 more
europepmc   +1 more source

Assessing the quality of antimalarial drugs in Equatorial Guinea: a follow-up study. [PDF]

BMJ Glob Health
Kaur H, Paris L, Mba Eyono JN, Nguema Avue RM, Phiri WP, Smith JM, Guerra CA, Riloha Rivas M, García GA.   +8 more
europepmc   +1 more source

Tiered manufacturing of pharmaceuticals as a commercial determinant of health: Implications for medicine quality and equity. [PDF]

PLOS Glob Public Health
Rusatira JC, Pal E, Uwimana JB, Khan A, Novoa MD, Suryanarayanan S, Schoukroun-Barnes L, Peterson C, Michtalik H, Kapeta AB, Mukanga D, Ahmed S, Lumpkin M, Preston C.   +13 more
europepmc   +1 more source

Barriers to accessing high-quality cancer medicines in Cameroon. A qualitative study of the views and practices of regulators and frontline healthcare providers. [PDF]

PLOS Glob Public Health
Saidu Y, Makia MC, Frambo A, Nang AN, Mulu A, Ashenef A, Benyam M, Chikowe I, Pastakia SD, Higgins CR, Paul N, Lieberman M.   +11 more
europepmc   +1 more source

Quality of different brands of clarithromycin tablets marketed in Ethiopia; implications for the future. [PDF]

JAC Antimicrob Resist
Bayu WT, Ketema G, Kassahun H, Meyer JC, Godman B, Mekonnen BA.   +5 more
europepmc   +1 more source

Protocol deviations in medicine quality tests. [PDF]

Bull World Health Organ
Mulatsari E, Saputro ID, Simanjuntak R, Ginanjar VA, Rahmawati A, Pisani E, Anggriani Y.   +6 more
europepmc   +1 more source

Estimated prevalence of unregistered and falsified medicinal products in Malaysia: a nationwide cross-sectional study conducted from March to November 2023. [PDF]

J Pharm Policy Pract
Abdul Karim KA, Ahmad AE, Abdullah MZ, Alias A, Setan S, Sulaiman MAA, Muhsin NI'.   +6 more
europepmc   +1 more source